Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
09.11.24 | Corvus Pharmaceuticals, Inc.: Corvus Pharmaceuticals Announces New Data Highlighting Potential of Ciforadenant to Overcome Immunotherapy Resistance in Metastatic Castration Resistant Prostate Cancer | 132 | GlobeNewswire (Europe) | BURLINGAME, Calif., Nov. 09, 2024 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS), a clinical-stage biopharmaceutical company, today announced new data highlighting the potential of... ► Artikel lesen | |
09.11.24 | Fate Therapeutics, Inc.: Fate Therapeutics Highlights Cancer-selective, HER2-Targeting Profile of FT825 / ONO-8250 CAR T-cell Product Candidate for Treatment of Advanced Solid Tumors at 2024 SITC Annual ... | 161 | GlobeNewswire (Europe) | Novel H2CasMab-2 Antigen Binding Domain Shown to Preferentially Target HER2 Expressed on Tumor Cells in Preclinical Studies Initial Low-Dose Cohort of FT825 / ONO-8250 as Monotherapy Shows Favorable... ► Artikel lesen | |
09.11.24 | Replimune Group Inc: Replimune Presents Late-Breaking Abstract Featuring Data from IGNYTE Clinical Trial of RP1 Combined with Nivolumab in Anti-PD1 Failed Melanoma at the 39th Annual Meeting of the Society ... | 110 | GlobeNewswire (Europe) | Oral presentation highlighting IGNYTE primary analysis data shows anti-tumor activity across all subgroups with injected and non-injected lesions responding with similar frequency, depth, duration... ► Artikel lesen | |
09.11.24 | Ultragenyx Pharmaceutical Inc.: Ultragenyx Presents Positive Update on GTX-102 Angelman Syndrome Program at FAST's 17th Annual Global Science Summit | 105 | GlobeNewswire (Europe) | Phase 1/2 data show improvements across all domains and confirm that Phase 3 Aspire study is amply powered to establish efficacy of GTX-102 Phase 3 program on track to begin enrollment by end-of-year... ► Artikel lesen | |
09.11.24 | WIPRO IT SERVICES LLC: GENERAL ANNOUNCEMENT::WIPRO LIMITED - INTIMATION UNDER REGULATION 30 OF SEBI LODR | - | SGX Company Announcements | ||
09.11.24 | There's a lot more Red Hulk in the new Captain America: Brave New World trailer | 2 | The Verge | ||
09.11.24 | Osisko Metals (CVE:OM) Hits New 52-Week High - Still a Buy? | 3 | MarketBeat | ||
09.11.24 | ECN Capital (TSE:ECN) Reaches New 52-Week High Following Analyst Upgrade | 2 | MarketBeat | ||
09.11.24 | RediShred Capital (CVE:KUT) Reaches New 52-Week High - What's Next? | 1 | MarketBeat | ||
09.11.24 | Urbana (TSE:URB) Sets New 1-Year High - Here's What Happened | 1 | MarketBeat | ||
09.11.24 | Oroco Resource (CVE:OCO) Sets New 12-Month Low - What's Next? | 5 | MarketBeat | ||
09.11.24 | Journey Energy (TSE:JOY) Sets New 12-Month Low - Here's Why | 21 | MarketBeat | ||
09.11.24 | Traffic: Neuer Besucherrekord bei ChatGPT, aber ein KI-Dienst legt noch stärker zu | 804 | t3n | ChatGPT hat im Oktober 2024 einen neuen Traffic-Rekord verzeichnet. Aber die Nutzer:innenzahlen von Googles KI-Dienst NotebookLM haben noch viel stärker zugelegt. Das liegt an einem ganz speziellen... ► Artikel lesen | |
09.11.24 | Einsatzkräfte simulieren Zugunglück - Großübung in Werder | 1 | Bahnblogstelle | ||
09.11.24 | ALK Abello: ALK licenses rights to neffy, the first approved adrenaline nasal spray for emergency treatment of allergic reactions (anaphylaxis) | 5 | GlobeNewswire (USA) | ||
09.11.24 | 3 small cap ASX shares to buy for massive returns | 2 | The Motley Fool Australia | ||
09.11.24 | This Magnificent Artificial Intelligence (AI) Stock Could Hit a $2 Trillion Valuation in the Next 3 Years | 4 | The Motley Fool | ||
09.11.24 | Can Anything Save Super Micro Computer? | 156 | The Motley Fool | ||
09.11.24 | 1 of the Biggest Reasons Behind Estée Lauder Stock's Plunge | 37 | The Motley Fool | ||
09.11.24 | The Junior Mining Market Is Back | 1 | The Deep Dive |
Suchbegriffe der letzen 24 h | Anzahl |
---|---|
RHEINMETALL | 1.891 |
RENK GROUP | 1.380 |
NVIDIA | 1.027 |
TUI | 944 |
SUPER MICRO COMPUTER | 814 |
BYD | 772 |
BAYER | 674 |
THYSSENKRUPP | 631 |
HENSOLDT | 612 |
INTEL | 599 |
TESLA | 593 |
FORMYCON | 588 |
EVOTEC | 573 |
PUMA | 489 |
VOLKSWAGEN | 425 |
COMMERZBANK | 423 |
BASF | 420 |
ALIBABA | 411 |
DEUTSCHE BANK | 397 |
NOVO NORDISK | 389 |
NEL | 371 |
MERCEDES-BENZ | 363 |
SIEMENS ENERGY | 329 |
DEUTSCHE TELEKOM | 312 |
VALNEVA | 306 |